Crossref
Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma
Annals of Pancreatic Cancer · 2026-11 · 9 · 32-32
DOI: 10.21037/apc-26-0032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-11. Verfasst von Michael Sestito und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sestito, M., & Boone, B. A. (2026). Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma. Annals of Pancreatic Cancer, 9, 32-32. https://doi.org/10.21037/apc-26-0032
Vancouver
Sestito M, Boone BA. Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma. Annals of Pancreatic Cancer. 2026;9:32-32. doi:10.21037/apc-26-0032
BibTeX
@article{Sestito2026,
author = {Sestito, Michael and Boone, Brian A.},
title = {Combining ERK and autophagy inhibition has limited response in metastatic pancreatic adenocarcinoma},
journal = {Annals of Pancreatic Cancer},
year = {2026},
volume = {9},
pages = {32--32},
doi = {10.21037/apc-26-0032}
}
EUVIMED